文献速递主动脉疾病

第三代与第二代支架移植物用于EVAR的器械特异性分析

Third- versus Second-Generation Stent Graft for Endovascular Aneurysm Repair: A Device-Specific Analysis.
PubMed 文献 · Ann Vasc Surg · 2017-05-04

单中心回顾性比较2008年5月至2015年12月择期EVAR中Excluder第二代(SIM-PULL,ExSP)与第三代(C3,ExC3)支架的结果。ExC3组合并症更多、解剖更不利,但手术时间与辐射暴露显著低于ExSP组,早期与中期结局无显著差异。

要点

  • ExC3组手术时间120 vs 151分钟(P=0.002),复杂病例129 vs 173分钟(P=0.004)。
  • ExC3组辐射剂量24,084 vs 32,548 cGy/cm2(P=0.020),复杂病例26,770 vs 41,104 cGy/cm2(P=0.003)。
  • 尽管ExC3组合并症更多、瘤颈成角更不利,早期与中期结局与ExSP组无显著差异。

核心结论

  • 第三代C3 Excluder较第二代SIM-PULL Excluder可减少辐射暴露和手术时间。
  • C3 Excluder在合并症更多和解剖更复杂的患者中仍获得与前一器械相当的结局。

研究设计与样本

  • 单中心回顾性比较研究,纳入2008年5月至2015年12月择期EVAR使用Excluder的患者64例(ExSP 24例,ExC3 40例)。
  • 平均随访31.6±22.9个月,按支架设计分组并识别复杂手术亚组。

主要发现

  • ExC3组吸烟史(P=0.019)、慢性心力衰竭和慢性肾脏病(均P=0.032)更多,瘤颈成角更不利(P=0.035)。
  • 总体手术时间120 vs 151分钟(P=0.002),复杂病例129 vs 173分钟(P=0.004)。
  • 总体辐射剂量24,084 vs 32,548 cGy/cm2(P=0.020),复杂病例26,770 vs 41,104 cGy/cm2(P=0.003)。
  • 造影剂用量无显著差异,早期和中期结局无显著组间差异。

临床怎么用

  • 在合并症更多、解剖更复杂的患者中,C3 Excluder可缩短手术时间并降低辐射暴露。
  • 器械选择时可考虑C3 Excluder以减少术中辐射和操作时间。

局限性

  • 单中心回顾性设计,样本量64例,随访时间有限。
  • 需进一步研究评估器械在更长随访期的表现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Our purpose is to analyze the outcomes of endovascular aneurysm repair (EVAR) in patients treated with Excluder endograft (W.L. Gore and Associate, Flagstaff, AZ), comparing second generation, featuring SIM-PULL delivery system (ExSP) and third generation, featuring C3 (ExC3), concerning intraprocedural data and long-term outcomes. METHODS: In our single-center, comparative study, we retrospectively analyzed all patients undergoing elective EVAR with Excluder from May 2008 to December 2015. This cohort was firstly divided according to the design of the endograft used, and then, two subgroups of complex procedures were identified according to International Standards. Preliminary end points were early- and mid-term outcomes. Primary end point was procedural data (i.e., procedural and fluoroscopy time, radiation dose (DAP), and contrast medium amount). RESULTS: The study included 64 patients (24 ExSP and 40 ExC3) with a mean follow-up of 31.6 ± 22.9 months. Patients in ExC3 group had significantly more risk factors (past or present history of smoking, P = 0.019), comorbidities (chronic heart failure and chronic kidney disease, both P = 0.032), as well as a more unfavorable anatomy (neck angulation, P = 0.035). Concerning preliminary outcome, no significant between-group difference was noted. As for intraoperative data, procedure duration was significantly shorter: 120 vs. 151 min (P = 0.002) in the overall population and 129 vs. 173 min (P = 0.004) in complex cases. A significant reduction was also found in fluoroscopy time and radiation exposure: 24,084 vs. 32,548 cGy/cm2 (P = 0.020) in the overall population and 26,770 vs. 41,104 cGy/cm2 (P = 0.003) in complex cases. No significant difference was found for contrast volume. CONCLUSIONS: The study shows that new C3 excluder enables to reduce radiation exposure and procedural time compared to the previous device. C3 excluder results are comparable to those of the previous device in spite of more comorbidities and complex anatomy of the treated patients. Further studies are needed to assess device performance on longer-term follow-up.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bergonti M, Teruzzi G, Santagostino G, et al. Third- versus Second-Generation Stent Graft for Endovascular Aneurysm Repair: A Device-Specific Analysis. Ann Vasc Surg. 2017. PMID: 28479470. doi:10.1016/j.avsg.2017.03.176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。